The OECD.AI Policy Navigator

Our policy navigator is a living repository from more than 80 jurisdictions and organisations. Use the filters to browse initiatives and find what you are looking for.

Centre for Artificial Intelligence in Precision Medicines


Added by:   National contact point
Added on:   18 Aug 2025
Updated by:   OECD analyst
Updated on:   16 Sep 2025

A leading global innovation center for developing precise therapies using artificial intelligence and emerging technologies.

Name in original language

مركز الذكاء الإصطناعي في العلاجات الدقيقة

Initiative overview

The objectives of this initiative include: 

  1. Accelerating the discovery of new therapeutics, for diseases with unmet needs. 
  2. Contributing to the Saudi 2030 vision by achieving a prosperous economy based on digitization. 
  3. Using artificial intelligence techniques in drug discovery. 
  4. Transferring and indigenizing technologies to build qualified Saudi cadres to advance scientific research in Saudi Arabia. 
  5. Building innovative start-up companies in the field of artificial intelligence. 
  6. Strengthening the partnership between research centres and prestigious bodies inside and outside the Kingdom to develop artificial intelligence technologies and drug discoveries. 
  7. Developing research and patents in the field of artificial intelligence and converting them into products of economic value. 
  8. Contributing to enhancing community health.

Name of responsible organisation (in English)

King Abdulaziz University (KAU)

Other relevant details

About the policy initiative


Organisation:

  • King Abdulaziz University (KAU)

Category:

  • National – AI policy initiatives, regulations, guidelines, standards and programmes or projects

Initiative type:

  • AI Research Centres/Centres of Excellence/Expertise, specialised AI teams, labs

Participating organisations:


Participating countries:


Status:

  • Active

Start Year:

  • 2022

Binding:

  • Non-binding

Other relevant urls: